Thank you to everyone who submitted an application for funding under the 2018 GESA Grants program. Thank you also to our sponsors and to those GESA members who made donations to fund the GESA Members Research Grants.
All the grants have now been awarded and every applicant has been sent an e-mail with the result of their application. If you have not received your notification e-mail please first check your Spam and Junk folders then send an e-mail to Mark at mdowd@gesa.org.au.
To all the successful applicants congratulations and well done. To those who were not successful this year thank you for taking the time to apply and remember that GESA offers a variety of grants, fellowships and awards each year so please consider applying again in 2019.
Grant Name |
Applications Open |
Applications Close |
Duration |
Grant Documentation |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GESA Dr Falk Pharma | 9am 21 Mar 2024 AEDT | midday 22 May 2024 AEST | 1 year | download | ||||||||
The 2025 GESA Dr Falk Pharma grants aims to provide funding for basic or clinical research in the field of Inflammatory Bowel Disease. The successful applicant will receive funding to the value of $40,000 (ex GST) for 12 months. | ||||||||||||
Applications must be submitted via the GESA Grants Management System (GESA Grants) by a GESA member who is to be the grant recipient. | ||||||||||||
GESA Mostyn Family Grant | 9am 21 Mar 2024 AEDT | midday 22 May 2024 AEST | 1 year | download | ||||||||
The 2024 GESA Mostyn Family Grant is to support innovative research to improve outcomes for patients with colorectal and pancreatic cancer. Specifically, research which will address the areas of bowel, colon or pancreatic cancers in Australia, from basic research to applied translational research including epidemiological and nutrition studies. | ||||||||||||
Applications must be submitted via the GESA Grants Management System (GESA Grants) by a GESA member who is to be the grant recipient. | ||||||||||||
GESA Mid-Career Grant Award | 9am 21 Mar 2024 AEDT | midday 22 May 2024 AEST | 1 year | download | ||||||||
The purpose of this 2024 GESA Grant Award is to support a full-time mid-career researcher associated with a research institute, university department or hospital who has demonstrated interest in research into health and disease related to the broad field of gastroenterology or hepatology. | ||||||||||||
The name of the 2024 award will reflect the research field of the grant recipient. If the researcher works in Hepatology: Lawrie Powell AC Grant Award, Gastroenterology: Barry Marshall Grant Award | ||||||||||||
GESA Rose Amarant Grant | 9am 22 Mar 2024 AEDT | midday 22 May 2024 AEST | 6 months | download | ||||||||
To provide funding to a gastroenterology unit or practice that treats inflammatory bowel disease (IBD) patient. Specifically, for a project based on the Quality Use of Medicines Principles or one that is related to the broader clinical aspects of IBD Management (e.g., a QUM project, patient well-being apps, paediatric or young teen project). | ||||||||||||
Applications must be submitted via the GESA Grants Management System (GESA Grants) by a GESA member who is to be the grant recipient. | ||||||||||||